The Antimalarial Effect of Curcumin Is Mediated by the Inhibition of Glycogen Synthase Kinase-3β
العنوان: | The Antimalarial Effect of Curcumin Is Mediated by the Inhibition of Glycogen Synthase Kinase-3β |
---|---|
المؤلفون: | Hasidah Mohd Sidek, Amatul Hamizah Ali, Suhaini Sudi, Rusliza Basir, Noor Embi |
المصدر: | Journal of Medicinal Food. 20:152-161 |
بيانات النشر: | Mary Ann Liebert Inc, 2017. |
سنة النشر: | 2017 |
مصطلحات موضوعية: | Male, 0301 basic medicine, Curcumin, Plasmodium berghei, 030231 tropical medicine, Medicine (miscellaneous), Parasitemia, Pharmacology, Antimalarials, Mice, 03 medical and health sciences, chemistry.chemical_compound, Curcuma, 0302 clinical medicine, In vivo, Interferon, GSK-3, medicine, Animals, Humans, Glycogen synthase, Mice, Inbred ICR, Glycogen Synthase Kinase 3 beta, Nutrition and Dietetics, biology, Plant Extracts, Tumor Necrosis Factor-alpha, Interleukin, biology.organism_classification, medicine.disease, Interleukin-10, Malaria, 030104 developmental biology, chemistry, biology.protein, Interleukin-4, medicine.drug |
الوصف: | Curcumin, a bioactive compound in Curcuma longa, exhibits various pharmacological activities, including antimalarial effects. In silico docking simulation studies suggest that curcumin possesses glycogen synthase kinase-3β (GSK3β)-inhibitory properties. The involvement of GSK3 in the antimalarial effects in vivo is yet to be demonstrated. In this study, we aimed to evaluate whether the antimalarial effects of curcumin involve phosphorylation of host GSK3β. Intraperitoneal administration of curcumin into Plasmodium berghei NK65-infected mice resulted in dose-dependent chemosuppression of parasitemia development. At the highest dose tested (30 mg/kg body weight), both therapeutic and prophylactic administrations of curcumin resulted in suppression exceeding 50% and improved median survival time of infected mice compared to control. Western analysis revealed a 5.5-fold (therapeutic group) and 1.8-fold (prophylactic group) increase in phosphorylation of Ser 9 GSK3β and 1.6-fold (therapeutic group) and 1.7-fold (prophylactic group) increase in Ser 473 Akt in liver of curcumin-treated infected animals. Following P. berghei infection, levels of pro- and anti-inflammatory cytokines, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-10, and IL-4 were elevated by 7.5-, 35.0-, 33.0-, and 2.2-fold, respectively. Curcumin treatment (therapeutic) caused a significant decrease (by 6.0- and 2.0-fold, respectively) in serum TNF-α and IFN-γ level, while IL-10 and IL-4 were elevated (by 1.4- and 1.8-fold). Findings from the present study demonstrate for the first time that the antimalarial action of curcumin involved inhibition of GSK3β. |
تدمد: | 1557-7600 1096-620X |
DOI: | 10.1089/jmf.2016.3813 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510f07380550a103fcbbd79f27bf8201 https://doi.org/10.1089/jmf.2016.3813 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....510f07380550a103fcbbd79f27bf8201 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15577600 1096620X |
---|---|
DOI: | 10.1089/jmf.2016.3813 |